Nectar Lifesciences Limited — Others, 13-12-2024: Rescission/termination(s)

Nectar Lifesciences Ltd. has rescinded its investment agreement with Isengard Direct PE LLC, following the latter's sale of all its shares by December 11, 2024. Consequently, the agreement, established in February 2010, is terminated, nullifying the rights granted to the investors, including matters related to preferential share issues and board memberships. This decision is unlikely to affect the company's management or control. For investors, this development may present a neutral impact as it removes previous obligations but reinforces independent governance, which could be viewed positively.